"With increasing economic pressure from rising drug costs and a strong industry influence, I was attracted to the area of lung cancer screening as a way to harness existing potential within our health care system," Dr. Sonya Cressman of The Canadian Centre for Applied Research in Cancer Control, said in a statement about her research, published in the Journal of Thoracic Oncology.

There has been controversy surrounding low-dose CT lung cancer screening — some studies make the case for it and others against it.


But a study published in CHEST in March found that structured counseling prior to screening, and visits with health care professionals, can help patients better understand the benefits and risks of lung cancer screening.

"This is the first study to show that this visit can improve a patient's understanding of lung cancer screening, allowing them to make a decision about participation that fits their values," Dr. Peter J. Mazzone, director of the Lung Cancer Screening Program at Cleveland Clinic and lead investigator of the study, said in a statement at the time.

Back to HCB News

CT Homepage